fda warning letters compounding semaglutide september 2025 issued a letter to a medical spa for failing to follow requirements that help ensure prescription drugs are safe and come from verified sources. These safeguards protect patients from potentially FDA Warns Companies Over Compounded

The sulfenic acid at Cys20 reacts with G-site bound GSH to generate a mixed disulfide (enzyme-S-S-G)

With the increase in social media, young people are already exposed to a diet culture and body images which may not be attainable and, ultimately, unhealthy

FeRD is highly prevalent among hospitalized COVID-19 patients and this clinical condition may continue for weeks or even months in PASC patients

One day, a small molecule that targets this metabolite by blocking its transporter could potentially forestall breast cancer metastasis, with fewer side-effects than sweeping therapies that target more general cellular processes